The value: why localisation pays off across global trials
June 26, 2026 | Localisation, clinical trials, translation
Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies run more smoothly, fairly and efficiently.
In our first two articles, we looked at where translation falls short and what good localisation actually looks like. Now we come to the part that affects timelines, budgets and trial delivery: the operational impact of getting localisation wrong.
Poor localisation rarely announces itself. It shows up quietly, in extra questions, slower processes, and avoidable rework. Strong localisation does the opposite. It keeps trials moving and helps sites focus on participants.
Where poor localisation creates friction
When materials don’t quite land, the effects ripple across sites and regions. Teams often see more site queries, with participants asking staff to explain content that should already be clear. Consent and onboarding slow down as confusion delays decisions. And when materials need revising market by market after launch, rework quickly builds.
These aren’t isolated problems. In our recent report The Site Factor, 27% of European respondents cited delays in receiving sponsor materials as their biggest barrier to enrolling participants. Just 24% of site teams say they use sponsor-provided materials, while others supplement them with their own materials or report having no participant-facing materials at all.
The hidden cost of fixing content late
Fixing localisation late is far more expensive than getting it right early. A single change to a master document can trigger updates across every language version, requiring fresh review, approval and redistribution. When amendments arrive out of sequence, sites are left unsure what to apply and when.
That uncertainty has a cost. It pulls site staff away from participants, adds review cycles, and risks inconsistency across regions. The later you spot the gap, the wider it spreads.
How strong localisation supports smoother delivery
Done well, localisation removes friction before it starts. Content arrives ready to use, reducing the burden on site teams to interpret, adapt or explain materials that participants find difficult to understand.
Across a trial, those benefits add up: fewer clarification queries for site staff, more consistent understanding across markets, smoother consent and onboarding processes, and less need for local workarounds or supplementary materials.
When participants understand what’s being asked of them, they’re more likely to engage and stay. And a better participant experience links directly to greater study completion.
Localisation, risk and diversity
Localisation isn’t just about clarity. It’s about reach. If your materials only work for some communities, your trial only reaches those communities. That limits diversity and skews representation, ultimately affecting the quality of the data generated.
Strong localisation helps you recruit fairly across regions and cultures. It reduces protocol misunderstandings, supports adherence, and lowers the risk of avoidable delays. In short, it makes trials more efficient and more representative.
Bringing the series together
Across these three articles, one idea has stayed constant. While translation carries the language, localisation carries the meaning.
That difference shapes how participants interpret, trust and engage with your trial. Treat localisation as a core part of your trial communication strategy, not a final production step, and you’ll see the value in smoother delivery, stronger engagement and better outcomes for everyone involved.
And that’s a goal worth building towards.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Flexible working: a fad or the future?
As the Flexible Working Bill gets written into UK law, we took a look at what this means for businesses of all sizes and specialities.
Looking for a job head first
During Health Information Week, we reflected on mental health and wellbeing within the workplace. Cuttsy+Cuttsy’s mental health first aider and HR Manager, Kate McCabe, shared some thoughts on what mental…
Patients as Partners – putting people first in clinical trials
Cuttsy+Cuttsy’s key takeaways from the Patients as Partners conference 2023
What are the ingredients for a perfect partnership?
Perfect partnerships can take many forms. Just like avocado and toast or tea and biscuits, all good on their own, but better together.
Cuttsy Cares Continues…
Cuttsy+Cuttsy’s charitable programme — Cuttsy Cares — has been running for the past 2 years, providing the team with the opportunity to support causes close to their hearts.
B-lown away by our first CDP rating
A catch up with Louise Jones, Cuttsy+Cuttsy’s sustainability officer, on what was achieved in 2022, the agency’s latest environmental assessment with CDP and a look ahead to 2023.
Cuttsy+Cuttsy campaign takes health literacy to the North Pole
Our 2022 Christmas campaign saw Santa’s agency elves creating tailored materials for patients. But were the examples guided by the principles of health literacy? Were they naughty or nice?
Celebrating award-winning patient-centricity
Every year, Cuttsy+Cuttsy choose to sponsor ‘Patient Programmes’ at the PM Society Digital awards. Here’s why.
Cuttsy+Cuttsy’s first EcoVadis rating comes back silver!
Louise Jones, Sustainability Officer at Cuttsy+Cuttsy celebrates their new silver sustainability rating
Cuttsy+Cuttsy gain highly regarded PIF Partner status
As official PIF Partners, Cuttsy+Cuttsy will be supporting the Patient Information Forum raise awareness of the PIF TICK.